Education program for quitting smoking
Official title: Investigation of the Effectiveness of Smoking Cessation Education in Patients Registered at a Community Mental Health Center: A Randomized Controlled Trial
Run by Erzurum Technical University · NCT06930547 · Data updated 2026-11-12
This study is testing an education program to help people with mental health disorders who smoke to quit by providing support from nurses.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Erzurum Technical University Academic / other |
| Locations | 1 site (Erzurum, Erzurum) |
| Status | Recruiting |
| Started | December 5, 2024 |
| Main results expected | May 5, 2025 |
| Study ends | August 15, 2025 |
| Registry record updated | April 16, 2025 |
| Trial ID | NCT06930547 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 years old who are registered with a community mental health center and smoke at least one cigarette per day.
✕Probably not a fit
Patients who are not in the remission phase of their mental health condition or those who smoke less than one cigarette per day may not benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This program focuses on educating individuals with mental health disorders about smoking cessation. It targets those who are registered with a community mental health center and are in remission, aiming to reduce the high smoking rates observed in this population. The intervention involves nurses who play a key role in supporting patients through the cessation process. Participants must be regular smokers and willing to engage in the program to receive support and resources for quitting.
Why it matters
Potential benefit: If successful, this program could significantly reduce smoking rates among individuals with mental health disorders, improving their overall health and quality of life.
How similar studies have gone: Other studies have shown success in smoking cessation programs tailored for individuals with mental health disorders, indicating that this approach is promising.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Being registered with TRSM (Community Mental Health Center) * Being in the remission phase (the period after the patient's treatment is completed, with no observed active symptoms and improved insight) * Smoking at least one cigarette per day regularly * Being open to communication and collaboration * Being over the age of 18 * Volunteering to participate in the study. Exclusion Criteria: * Not being registered with TRSM (Community Mental Health Center) * Not being in the remission phase (presence of active symptoms or lack of improved insight) * Smoking less than one cigarette per day * Being unwilling or unable to communicate and collaborate effectively * Being under the age of 18 * Not volunteering or unwilling to participate in the study.
Where it's running
-
Erzurum Community Mental Health Center
Erzurum, Erzurum, Turkey (Türkiye) Recruiting
Study contacts
- Principal investigator: Zeynep ÖZTÜRK, PHD — Erzurum Technical University
- Study coordinator: Zeynep ÖZTÜRK, PHD
- Email: zeynepolcun6@gmail.com
- Phone: 90539-796-88-99
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Multilevel program to increase LDCT lung cancer screening and help African American smokers quit
This program will try combining low-dose CT screening with culturally tailored smoking-cessation support to help African American smokers who are eligible for LDCT quit and get screened.
-
Ear acupressure plus nicotine replacement to ease withdrawal in psychiatric inpatients
This study will test whether adding ear acupressure (ear seeds) to standard nicotine replacement therapy helps psychiatric inpatients who must stop smoking reduce withdrawal symptoms, cravings, and anxiety.
-
Quitting Matters: a smoking quit program for people living with HIV
This 6-month program will test whether a tailored smartphone app plus nicotine patches and gum helps people living with HIV quit smoking better than a standard quit app.
-
tDCS plus varenicline to help people quit smoking
This will test if adding noninvasive tDCS brain stimulation to varenicline helps adults who smoke at least 8 cigarettes a day quit and stay smoke-free.
-
Effects of Cytisinicline on Smoking Cues in Daily Smokers
This study tests if a medication called cytisinicline can help daily smokers reduce their cravings and reactions to cigarette-related triggers.
-
Smoky Futures: Danish Adolescent Nicotine Use over Time
This observational cohort follows Danish youths ages 15–25 to see how cigarette, e-cigarette, and other nicotine use begin, change, and affect health and education over several years.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.